- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2016
- Public Summary Document (PSD) July 2016 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2016 PBAC Meeting - Word
Brivaracetam – July 2016
Brivaracetam: 25 mg tablet, 56, 50 mg tablet, 56, 75 mg tablet, 56, 100 mg tablet, 56, 10 mg/mL, 300 mL, Briviact®
Last updated
11 November 2016